Caeruleus Genomics

Caeruleus Genomics is a computational biotechnology company focused on developing a proprietary single-cell sequencing platform. This platform enables accurate long-read sequencing at scale, integrating wet lab techniques with machine-learning capabilities. The technology allows for functional and unbiased profiling of complex RNA dysregulation across large cell populations, facilitating the identification and isolation of rare cell types. By discovering novel therapeutic targets that may have been previously undruggable, Caeruleus Genomics supports the development of more effective therapies. The company collaborates with organizations engaged in targeted immunotherapies and genetic medicines, addressing various diseases through its innovative approach to cell profiling and target discovery.